Taft Pharmaceutical and Life Sciences attorney Roshan Shrestha will present “Rule 12 Motions in Hatch Waxman Cases in 2019” at the 9th Annual Pharma IPR Conference in Mumbai, India on March 4-6, 2020. The conference brings together key stakeholders, IP Attorneys and Counsels from across the globe to discuss, deliberate and share their thoughts on achieving the next phase of growth, recent trends and best practices in the Pharma IPR space. More information is here.
Shrestha focuses his practice on all aspects of intellectual property law, including patent litigation, prosecution and opinion work in the chemical, pharmaceutical and electronic material arts. He has a broad scope of pharmaceutical and life sciences capabilities, including Hatch-Waxman litigation and inter partes review proceedings at the USPTO. Shrestha has been recognized by Super Lawyers as a Rising Star since 2014. In 2016, he was named to Law Bulletin’s “40 Illinois Attorneys Under 40 to Watch.” Before practicing law, Shrestha was a research scientist at Los Alamos National Laboratory in New Mexico, where his investigation on materials for hydrogen storage technology received several patents.